An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs-Reference-Cited by-同舟云学术

An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs

Published:2003-01-10 Issue:4 Volume:13 Page:605-619
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Todd Susan¹²

Affiliation:

1. a Medical and Pharmaceutical Statistics Research Unit , School of Applied Statistics , The University of Reading , Earley Gate, Reading, UK

2. b Medical and Pharmaceutical Statistics Research Unit , School of Applied Statistics , The University of Reading , P.O. Box 240, Earley Gate, Reading, RG6 6FN, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1081/BIP-120024197

Reference20 articles.

1. Repeated Significance Tests on Accumulating Data

2. Evaluation of Experiments with Adaptive Interim Analyses

3. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

4. Interim monitoring of bivariate responses using repeated confidence intervals

5. Guidelines for Monitoring Efficacy and Toxicity Responses in Clinical Trials

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical and analytical considerations when performing interim analyses in diagnostic test accuracy studies;Diagnostic and Prognostic Research;2024-08-20

2. Group sequential designs for clinical trials with bivariate endpoints;Statistics in Medicine;2020-08-10

3. Analysis of Two-Stage Adaptive Trial Designs;Biopharmaceutical Applied Statistics Symposium;2018

4. Sample Size Calculations in Clinical Research: Third Edition;CH CRC BIOSTAT SER;2017-08-15

5. Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rate;Journal of Biopharmaceutical Statistics;2015-11-17